Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app hypnotize away back pain?

NCT ID NCT06984354

Recruiting now Symptom relief Sponsor: Neuroscience Research Australia Source: ClinicalTrials.gov ↗

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This trial tests whether a mobile app that combines pain education with clinical hypnosis can reduce pain and disability in people with chronic low back pain. About 720 adults who are seeing their general practitioner for back pain will either use the app for 8 weeks or receive a standard informational factsheet. The goal is to see if the app offers a more effective, accessible way to manage chronic back pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A mobile app delivering pain education and clinical hypnosis sessions
What this could lead to
If effective, this app could offer a scalable, accessible, drug-free option to help people with chronic back pain reduce pain and improve daily function.
What could go wrong
The trial is early-stage and results may not apply to everyone. The app's success depends on user engagement, and hypnosis may not work for all individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN (BACK / NECK) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Back Pain Chronic Pain chronic pain syndrome Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN (BACK / NECK) DIGITAL HEALTH GENERAL PRACTICE (GP), PRIMARY CARE SETTINGS HYPNOSIS, CHRONIC PAIN MANAGEMENT LOW BACK PAIN PATIENT EDUCATION

Contacts and locations

Locations

  • Neuroscience Research Australia

    RECRUITING

    Randwick, New South Wales, 2031, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.